Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

By M. Omata, L. A. Lesmana, R. Tateishi, Pei‐Jer Chen, Shi-Ming Lin, H. Yoshida, M. Kudo, Jeong Min Lee, B. Choi, R. Poon and 15 more. Hepatology International, 2010

1,052 citations recorded by the source corpus.

IntroductionThe Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on the management of hepatocellular carcinoma (HCC) in December 2008 to develop consensus recommendations.MethodsThe working party consisted of expert hepatologist, hepatobiliary surgeon, radiologist, and oncologist from Asian-Pacific region, who were requested to make drafts prior to the consensus meeting held at Bali, Indonesia on 4 December 2008. The quality of existing evidence and strength of recommendations were ranked from 1 (highest) to 5 (lowest) and from A (strongest) to D (weakest), respectively, according to the Oxford system of evidence-based approach for developing the consensus statements.ResultsParticipants of the consensus meeting assessed the quality of cited studies and assigned grades to the recommendation statements. Finalized recommendations were presented at the fourth APASL single topic conference on viral-related HCC at Bali, Indonesia and approved by the participants of the conference.

Subfields: Epidemiology, Hepatology, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/ffd01b0bad9a3257876924654aa2b30692989912

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Ken-Nan Kuo
2. M. Kudo
3. Chun-Ying Wu
4. M. Sherman
5. Yao-Chun Hsu
6. Lewis R. Roberts
7. Jaw-Town Lin
8. H. Ho

In Hepatology

1. Lewis R. Roberts
2. M. Kudo
3. M. Colombo
4. M. Sherman
5. A. Cheng
6. Jordi Bruix1 , 2
7. J. Llovet

In Statistics and Probability

1. Ken-Nan Kuo
2. Chun-Ying Wu
3. Yao-Chun Hsu
4. Jaw-Town Lin
5. H. Ho
6. Ming-Shiang Wu
7. Yi-Ju Chen

Citations in the corpus

• Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study (2015, methodology): “0 907 (52) 1328 (44) 3445 (41) 1286 (82) 734 (63) 403 (91) 1 621 (36) 1325 (43) 4663 (56) 238 (15) 414 (35) 33 (7) >1 208 (12) 398 (13) 255 (3) 41 (3) 21 (2) 7 (2)”
• Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection. (2012, result): “in HCC recurrence, studies regarding the effectiveness of nucleoside analogues in HCC recurrence have been very limited and have produced conflicting results.(28) Based on a study of 14 patients receiving lamivudine and 10 control participants, Kubo et al(13) found a lower 5-year HCC disease-free su”
• Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update (2015, background): “HCC screening and surveillance in patients with HBV infection have been covered in detail in APASL consensus recommendations on HCC [356].”
• Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (2017, background): “This section of the guidelines is markedly revised from the APASL 2010 guidelines [4].”